查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762354

高分子药物研发外包市场，规模，占有率，产业分析报告:各类服务，工作流程，各治疗领域，各最终用途，各地区，2025年～2034年的市场预测

Large Molecule Drug Discovery Outsourcing Market Size, Share, & Industry Analysis Report: By Service (Chemistry Services and Biology Services), By Workflow, By Therapeutics Area, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2034年，聚合物药物发现外包市场规模将达到65.3亿美元。该报告深入分析了当前的市场动态，并分析了未来的市场成长。

聚合物药物发现外包是指将早期生物研究活动（例如标靶验证、关键标靶识别和候选药物优化）外包给专业的外部合作伙伴，以提高效率和创新能力。生物製剂和新型疗法日益受到关注，这需要公司内部难以获得的专业能力，这进一步支持了其成长机会。随着生物製药公司寻求加速单株抗体、融合蛋白和核酸类药物等复杂聚合物的研发，将研发工作外包给拥有合适技术和科研专长的合约研究组织 (CRO) 已成为策略上的必然选择。这种方法可以优化资源利用率，缩短早期发现时间，同时维持较高的科学标准。

人工智慧驱动的药物发现、生物资讯学和高通量筛选平台等先进技术日益融入外包模式，正在塑造聚合物药物发现外包市场的需求。这些工具改进了数据分析、预测模型和分子设计，使 CRO 能够提供更精准、更有效率的药物发现流程。随着生物製剂领域竞争的加剧，企业越来越重视能够提供更快週转时间、更深入的生物机制洞察以及更高识别可行候选药物可能性的技术支援型合作伙伴。这种向技术驱动型外包合作的转变预计将重新定义聚合物药物发现领域的创新速度和品质。

聚合物药物发现外包市场报告重点

按工作流程划分，先导化合物鑑定和候选化合物优化细分市场在2024年占据了最大的市场占有率。这是因为这些细分市场在纯化先导化合物以确保生物製剂开发中的最佳疗效、安全性和类药特性方面发挥关键作用。

按服务划分，化学服务细分市场预计将显着扩张，这得益于改善聚合物药物候选化合物的结构完整性、稳定性和功能性的重要性。

2024年，北美将占据最大的收入占有率，这得益于其成熟的生物製药行业、强劲的研发投入以及强大的生物製剂研究机构网络。

在预测期内，亚太地区的聚合物药物发现外包市场预计将快速成长，这得益于外包业务的成长。需求、成本优势以及专门从事生物製剂研究的开发基础设施。

全球主要的市场开发公司包括 Charles River Laboratories、Dalton Pharma Services、Domainex、Eurofins Discovery、Evotec SE、GenScript、Jubilant Biosys Limited、Labcorp.（Covance）、Merck &Co. Inc.、Pharmaceutical Product Development, LLC（PPD，赛默飞世尔科技公司） Ltd. 和药明康德。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球高分子药物研发外包市场洞察

  • 市场概述
  • 高分子药物研发外包市场动态
    • 促进因素和机会
      • 不断增加的合作伙伴关係和基于平台的合作
      • 药物发现技术的进步
    • 限制与课题
      • 关税导致供应链中断和成本上升
  • PESTEL分析
  • 高分子药物研发外包市场趋势
  • 价值链分析

第5章 按全球高分子药物研发外包市场:工作流程

  • 主要调查结果
  • 简介
  • 目标的特定和筛检
  • 与目标检验功能资讯科学
  • 领导特定和候选人最佳化
  • 前临床开发
  • 其他

第6章 全球高分子药物研发外包市场:各类服务

  • 主要调查结果
  • 简介
  • 化学服务
  • 生物学服务

第7章 全球高分子药物研发外包市场:各治疗领域

  • 主要调查结果
  • 简介
  • 呼吸系统
  • 疼痛与麻醉
  • 肿瘤学
  • 眼科
  • 血液学
  • 其他

第8章 全球高分子药物研发外包市场:各最终用途

  • 主要调查结果
  • 简介
  • 医药品·生物科技
  • 学术机构

第9章 全球高分子药物研发外包市场:各地区

  • 主要调查结果
  • 简介
    • 高分子药物研发外包市场分析:各地区，2020～2034年
  • 北美
    • 北美:工作流程，2020～2034年
    • 北美:各类服务，2020～2034年
    • 北美:各治疗领域，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:工作流程，2020～2034年
    • 欧洲:各类服务，2020～2034年
    • 欧洲:各治疗领域，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:工作流程，2020～2034年
    • 亚太地区:各类服务，2020～2034年
    • 亚太地区:各治疗领域，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:工作流程，2020～2034年
    • 中东·非洲:各类服务，2020～2034年
    • 中东·非洲:各治疗领域，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:工作流程，2020～2034年
    • 南美:各类服务，2020～2034年
    • 南美:各治疗领域，2020～2034年
    • 南美:各最终用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Charles River Laboratories
  • Dalton Pharma Services
  • Domainex
  • Eurofins Discovery
  • Evotec SE
  • GenScript
  • Jubilant Biosys Limited
  • Labcorp.(Covance)
  • Labcorp.(Covance)
  • Pharmaceutical Product Development, LLC(PPD, part of Thermo Fisher)
  • Pharmaron
  • QIAGEN
  • Syngene International Limited
  • TCG Lifesciences Pvt Ltd.
  • WuXi AppTec
Product Code: PM5755

The large molecule drug discovery outsourcing market size is expected to reach USD 6.53 billion by 2034, according to a new study by Polaris Market Research. The report "Large Molecule Drug Discovery Outsourcing Market Share, Size, Trends, Industry Analysis Report By Service (Chemistry Services and Biology Services), By Workflow, By Therapeutics Area, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Large molecule drug discovery outsourcing refers to the delegation of early-stage biologic research activities, such as target validation, HIT identification, and candidate optimization to specialized external partners to improve efficiency and innovation. The increasing focus on biologics and novel therapeutic modalities, which demand specialized capabilities not readily available in house, further contributes to the growth opportunities. Outsourcing to contract research organizations (CROs) with the right technological and scientific expertise has become a strategic necessity as biopharmaceutical companies seek to accelerate the development of complex large molecules such as monoclonal antibodies, fusion proteins, and nucleic acid-based drugs. This approach optimizes resource utilization and reduces early-stage discovery timelines while maintaining high scientific standards.

The growing integration of advanced technologies such as AI-driven drug discovery, bioinformatics, and high-throughput screening platforms into outsourcing models shapes the large molecule drug discovery outsourcing market demand. These tools improve data analysis, predictive modeling, and molecular design, encouraging CROs to offer more precise and efficient discovery processes. Companies are increasingly prioritizing technology-enabled partners who provide faster turnaround, deeper insight into biological mechanisms, and a higher chance of identifying feasible drug candidates as competition increases in the biologics space. This shift toward tech-driven outsourcing partnerships is expected to redefine the pace and quality of innovation across the large-molecule drug discovery landscape.

Large Molecule Drug Discovery Outsourcing Market Report Highlights

In terms of workflow, the lead identification and candidate optimization segment held the largest market share in 2024, owing to its critical role in refining lead compounds to ensure optimal therapeutic efficacy, safety, and drug-like properties for biologics development.

Based on service, the chemistry services segment is poised for notable expansion, fueled by its importance in enhancing the structural integrity, stability, and functionality of large-molecule drug candidates.

In 2024, North America accounted for the largest revenue share, supported by its mature biopharmaceutical industry, strong R&D investments, and a robust network of biologics-focused research organizations.

The Asia Pacific large molecule drug discovery outsourcing market is anticipated to experience rapid growth during the forecast period, driven by rising outsourcing demand, cost advantages, and the increasing establishment of specialized biologics research infrastructure.

A few global key market players include Charles River Laboratories; Dalton Pharma Services; Domainex; Eurofins Discovery; Evotec SE; GenScript; Jubilant Biosys Limited; Labcorp. (Covance); Merck & Co., Inc.; Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher); Pharmaron; QIAGEN; Syngene International Limited; TCG Lifesciences Pvt Ltd.; and WuXi AppTec.

Polaris Market Research has segmented the large molecule drug discovery outsourcing market report on the basis of workflow, service, therapeutics area, end use, and region:

By Workflow Outlook (Revenue, USD Billion, 2020-2034)

Target Identification & Screening

Target Validation & Functional Informatics

Lead Identification & Candidate Optimization

Preclinical Development

Others

By Service Outlook (Revenue, USD Billion, 2020-2034)

Chemistry Services

Biology Services

By Therapeutics Area Outlook (Revenue, USD Billion, 2020-2034)

Respiratory system

Pain and Anesthesia

Oncology

Ophthalmology

Hematology

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical & Biotechnology

Academic Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Large Molecule Drug Discovery Outsourcing Market Insights

  • 4.1. Large Molecule Drug Discovery Outsourcing Market - Market Snapshot
  • 4.2. Large Molecule Drug Discovery Outsourcing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Partnerships and Platform-Based Collaboration
      • 4.2.1.2. Increasing Advancements in Drug Discovery Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Supply chain disruptions and increased costs due to tariffs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Large Molecule Drug Discovery Outsourcing Market Trends
  • 4.6. Value Chain Analysis

5. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • 5.3. Target Identification & Screening
    • 5.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Target Identification & Screening, by Region, 2020-2034 (USD Billion)
  • 5.4. Target Validation & Functional Informatics
    • 5.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Target Validation & Functional Informatics, by Region, 2020-2034 (USD Billion)
  • 5.5. Lead Identification & Candidate Optimization
    • 5.5.1. Global Large Molecule Drug Discovery Outsourcing Market, by Lead Identification & Candidate Optimization, by Region, 2020-2034 (USD Billion)
  • 5.6. Preclinical Development
    • 5.6.1. Global Large Molecule Drug Discovery Outsourcing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Large Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Large Molecule Drug Discovery Outsourcing Market, by Service

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • 6.3. Chemistry Services
    • 6.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Chemistry Services, by Region, 2020-2034 (USD Billion)
  • 6.4. Biology Services
    • 6.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Biology Services, by Region, 2020-2034 (USD Billion)

7. Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Respiratory system, 2020-2034 (USD Billion)
  • 7.3. Respiratory system
    • 7.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pharmaceuticals & Biotechnology, by Region, 2020-2034 (USD Billion)
  • 7.4. Pain and Anesthesia
    • 7.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pain and Anesthesia, by Region, 2020-2034 (USD Billion)
  • 7.5. Oncology
    • 7.5.1. Global Large Molecule Drug Discovery Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.6. Ophthalmology
    • 7.6.1. Global Large Molecule Drug Discovery Outsourcing Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
  • 7.7. Hematology
    • 7.7.1. Global Large Molecule Drug Discovery Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Large Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Large Molecule Drug Discovery Outsourcing Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Pharmaceuticals & Biotechnology
    • 8.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pharmaceuticals & Biotechnology, by Region, 2020-2034 (USD Billion)
  • 8.4. Academic Institutes
    • 8.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)

9. Global Large Molecule Drug Discovery Outsourcing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Large Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Large Molecule Drug Discovery Outsourcing Market - North America
    • 9.3.1. North America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.3.2. North America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.3.3. North America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.3.4. North America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5. Large Molecule Drug Discovery Outsourcing Market - US
      • 9.3.5.1. US: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6. Large Molecule Drug Discovery Outsourcing Market - Canada
      • 9.3.6.1. Canada: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4. Large Molecule Drug Discovery Outsourcing Market - Europe
    • 9.4.1. Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5. Large Molecule Drug Discovery Outsourcing Market - UK
      • 9.4.5.1. UK: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6. Large Molecule Drug Discovery Outsourcing Market - France
      • 9.4.6.1. France: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7. Large Molecule Drug Discovery Outsourcing Market - Germany
      • 9.4.7.1. Germany: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8. Large Molecule Drug Discovery Outsourcing Market - Italy
      • 9.4.8.1. Italy: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9. Large Molecule Drug Discovery Outsourcing Market - Spain
      • 9.4.9.1. Spain: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10. Large Molecule Drug Discovery Outsourcing Market - Netherlands
      • 9.4.10.1. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11. Large Molecule Drug Discovery Outsourcing Market - Russia
      • 9.4.11.1. Russia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12. Large Molecule Drug Discovery Outsourcing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5. Large Molecule Drug Discovery Outsourcing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5. Large Molecule Drug Discovery Outsourcing Market - China
      • 9.5.5.1. China: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6. Large Molecule Drug Discovery Outsourcing Market - India
      • 9.5.6.1. India: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7. Large Molecule Drug Discovery Outsourcing Market - Malaysia
      • 9.5.7.1. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8. Large Molecule Drug Discovery Outsourcing Market - Japan
      • 9.5.8.1. Japan: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9. Large Molecule Drug Discovery Outsourcing Market - Indonesia
      • 9.5.9.1. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10. Large Molecule Drug Discovery Outsourcing Market - South Korea
      • 9.5.10.1. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11. Large Molecule Drug Discovery Outsourcing Market - Australia
      • 9.5.11.1. Australia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12. Large Molecule Drug Discovery Outsourcing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6. Large Molecule Drug Discovery Outsourcing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5. Large Molecule Drug Discovery Outsourcing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6. Large Molecule Drug Discovery Outsourcing Market - UAE
      • 9.6.6.1. UAE: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7. Large Molecule Drug Discovery Outsourcing Market - Israel
      • 9.6.7.1. Israel: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8. Large Molecule Drug Discovery Outsourcing Market - South Africa
      • 9.6.8.1. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9. Large Molecule Drug Discovery Outsourcing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7. Large Molecule Drug Discovery Outsourcing Market - Latin America
    • 9.7.1. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5. Large Molecule Drug Discovery Outsourcing Market - Mexico
      • 9.7.5.1. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6. Large Molecule Drug Discovery Outsourcing Market - Brazil
      • 9.7.6.1. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7. Large Molecule Drug Discovery Outsourcing Market - Argentina
      • 9.7.7.1. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8. Large Molecule Drug Discovery Outsourcing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Charles River Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Dalton Pharma Services
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Domainex
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eurofins Discovery
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Evotec SE
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GenScript
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Jubilant Biosys Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Labcorp. (Covance)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Labcorp. (Covance)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Pharmaron
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. QIAGEN
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Syngene International Limited
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. TCG Lifesciences Pvt Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. WuXi AppTec
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables:

  • Table 1 Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 2 Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 3 Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 4 Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 North America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 6 North America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 7 North America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 8 North America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 US: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 10 US: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 11 US: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 12 US: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Canada: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 14 Canada: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 15 Canada: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 16 Canada: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 18 Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 19 Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 20 Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 UK: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 22 UK: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 23 UK: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 24 UK: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 France: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 26 France: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 27 France: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 28 France: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Germany: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 30 Germany: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 31 Germany: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 32 Germany: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Italy: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 34 Italy: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 35 Italy: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 36 Italy: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Spain: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 38 Spain: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 39 Spain: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 40 Spain: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Russia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 46 Russia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 47 Russia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 48 Russia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 China: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 58 China: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 59 China: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 60 China: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 India: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 62 India: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 63 India: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 64 India: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 69 Japan: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 70 Japan: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 71 Japan: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 72 Japan: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 77 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 78 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 79 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 80 South Korea: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Australia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 82 Australia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 83 Australia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 84 Australia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 UAE: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 98 UAE: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 99 UAE: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 100 UAE: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Israel: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 102 Israel: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 103 Israel: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 104 Israel: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 105 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 106 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 107 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 108 South Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 113 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 114 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 115 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 116 Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 117 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 118 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 119 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 120 Mexico: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 122 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 123 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 124 Brazil: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 125 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 126 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 127 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 128 Argentina: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Large Molecule Drug Discovery Outsourcing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Workflow
  • Figure 7. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Service
  • Figure 9. Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Therapeutics Area
  • Figure 11. Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End Use
  • Figure 13. Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2024 & 2034 (USD Billion)
  • Figure 14. Global Large Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • Figure 15. Strategic Analysis - Global Large Molecule Drug Discovery Outsourcing Market